Skip to content
Business Times – Lifestyle
Author:
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
March 26, 2026
←
Previous Page
1
2